MACC1 and cholangiocarcinoma: The prediction of this axis can provide us with a clue that COL18A1-AS1 and hsa-mir-1295b may participate in the protumor process of MACC1 and these molecules may become novel diagnostic biomarkers and therapeutic targets for CCA.